comparemela.com
  1. Home
  2. Live Updates
  3. Outcomes Research Ltd - Breaking News

Latest Breaking News On - Outcomes research ltd - Page 1 : comparemela.com

Chronic Kidney Disease - Market Insight, Epidemiology and Market Forecast 2023-2032: With Focus on United States, EU4 (Germany, Spain, Italy, and France), the United Kingdom, and Japan

/PRNewswire/ The "Chronic Kidney Disease - Market Insight, Epidemiology And Market Forecast - 2032" report has been added to ResearchAndMarkets.com s.

United statesUnited kingdomSouth koreaHong kongEli lillyLaura woodKibow pharmaCincor pharmaUniversite claude bernardNovo nordiskReata pharmaceuticals incHealth canadaLexicon pharmaceuticalsE st office hours callAllena pharmaceuticalsKings college hospital

Dapagliflozin is not only clinically effective, but also cost effective in patients with chronic kidney disease

Dapagliflozin is not only clinically effective, but also cost effective in patients with chronic kidney disease
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomPhil mcewanSmith klineVifor freseniusJohnjv mcmurrayRyan millerDavidc wheelerKlas bergenheimHiddojl heerspinkOliver darlingtonJuan jose garcia sanchezDaichii sankyoAndrew briggsBoehringer ingelheimMerck co

Diabetes Drug Dapagliflozin Proves Effective in Kidney Disease Patients

Dapagliflozin, the drug used to treat diabetes was found to be a cost-effective treatment in patients with chronic kidney disease in addition to standard care.

United kingdomPhil mcewanPhd health economicsOutcomes research ltdChronic kidney diseaseHealth economicsKidney disease treatment

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.